Stock Fundamentals

Company Information

Company Name
XBiotech Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA98400H1029
CIK: 0001626878
CUSIP: 98400H102
Currency: USD
Full Time Employees: 87
Phone: 512 386 2900
Fiscal Year End: December
IPO Date: Apr 15, 2015
Description:

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Address:

5217 Winnebago Lane, Austin, TX, United States, 78744

Directors & Officers

Name Title Year Born
Mr. John Simard Founder & Chairman 1962
Dr. Sushma Shivaswamy Ph.D. Interim CEO & Chief Scientific Officer 1978
Ms. Angela Hu Director of Finance 1984
Dr. Qian Wu Senior Vice President of Clinical Operations & Analytical Quality NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 14, 2021 John Simard N/A Sale 21.13K $12.90 $272.51K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 299.56K Dec 31, 2025 0.98% $0.00 -63.43%
BlackRock Inc 293.10K Mar 31, 2026 0.96% $0.00 1.55%
Geode Capital Management, LLC 231.02K Mar 31, 2026 0.76% $0.00 4.48%
Vanguard Capital Management, LLC 200.97K Mar 31, 2026 0.66% $0.00 0.00%
RBF LLC 198.50K Mar 31, 2026 0.65% $0.02 -50.00%
Morgan Stanley - Brokerage Accounts 165.55K Mar 31, 2026 0.54% $0.00 1.31%
Millennium Management LLC 105.54K Mar 31, 2026 0.35% $0.00 -22.08%
Bridgeway Capital Management, LLC 98.45K Mar 31, 2026 0.32% $0.00 9.94%
Vanguard Fiduciary Trust Co 91.58K Mar 31, 2026 0.30% $0.00 0.00%
Northern Trust Corp 76.09K Mar 31, 2026 0.25% $0.00 -0.46%
State Street Corp 73.01K Mar 31, 2026 0.24% $0.00 0.00%
Jane Street Group LLC 60.10K Mar 31, 2026 0.20% $0.00 -13.82%
Empowered Funds, LLC 59.55K Mar 31, 2026 0.20% $0.00 0.00%
Squarepoint Ops LLC 41.21K Mar 31, 2026 0.14% $0.00 -35.61%
Bank of New York Mellon Corp 39.36K Mar 31, 2026 0.13% $0.00 -18.77%
Bank of America Corp 36.69K Mar 31, 2026 0.12% $0.00 2.21%
Dimensional Fund Advisors, Inc. 36.05K Mar 31, 2026 0.12% $0.00 -28.88%
Connor Clark & Lunn Inv Mgmt Ltd 28.66K Mar 31, 2026 0.09% $0.00 -5.18%
BNP Paribas Arbitrage, SA 27.16K Mar 31, 2026 0.09% $0.00 1.12%
NATIONAL BANK OF CANADA /FI/ 25.00K Mar 31, 2026 0.08% $0.00 0.00%

Shares Statistics

Shares Outstanding: 30.49M
Shares Float: 22.84M
% Insiders: 2,432.70%
% Institutions: 683.60%
Short % Float: 0.70%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Institutional Extnd Mkt Idx Tr 200.97K 0.66% ▲ 0.00% Apr 30, 2026
2 Fidelity Extended Market Index 110.50K 0.36% ▼ 0.36% Apr 30, 2026
3 EA Bridgeway Omni Small-Cap Value ETF 59.55K 0.20% ▲ 0.00% May 29, 2026
4 iShares Micro-Cap ETF 51.97K 0.17% ▲ 0.00% May 29, 2026
5 Bridgeway Ultra-Small Company 38.90K 0.13% ▲ 29.67% Mar 31, 2026
6 Extended Equity Market Fund E 37.08K 0.12% ▲ 0.00% Dec 31, 2025
7 Extended Equity Market Fund B 37.08K 0.12% ▲ 0.00% Dec 31, 2025
8 Blackrock Extended Mkt Fund CF 37.08K 0.12% ▲ 0.00% Apr 30, 2026
9 Fidelity Total Market Index 35.15K 0.12% ▲ 0.00% Apr 30, 2026
10 BlackRock Extended Equity Market Fund K 31.57K 0.10% ▼ 0.73% Mar 31, 2026

Valuation Metrics

Enterprise Value: $-91.09M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $71.34M
EBITDA: $-46.83M
PEG Ratio: $0.00
Book Value: $4.60
Earnings/Share: $-1.31
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -18.81%
ROE (TTM): -25.93%
Revenue (TTM): $300.00K
Revenue/Share (TTM): $0.01
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -93.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 16.01x 0.00x 0.06x -632.78x 0.00x
2024-12-31 11.56x 0.06x 0.08x -52.63x -0.28x
2023-12-31 33.07x 0.00x 0.03x N/A 0.00x
2022-12-31 54.07x 0.00x 0.02x -38.24x 0.00x
2021-12-31 71.49x 0.00x 0.02x -23.07x 0.00x
2020-12-31 81.80x 0.00x 0.01x -2.04x 0.00x
2019-12-31 11.90x 0.00x 0.07x -0.04x 0.00x
2018-12-31 5.78x 0.00x 0.07x N/A 0.00x
2017-12-31 11.94x 0.00x 0.04x N/A 0.00x
2016-12-31 4.64x 0.00x 0.12x N/A 0.00x
2015-12-31 14.79x 0.00x 0.06x N/A 0.00x
2014-12-31 18.45x 0.00x 0.05x N/A 0.00x
2013-12-31 9.10x 0.00x 0.08x N/A 0.00x
2012-12-31 4.09x 0.00x 0.13x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about XBIT.US!